Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00330460
What this trial is testing

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

Who this might be right for
OsteoporosisOsteopenia
Amgen 1,189
Large-scale testing (Phase 3)Study completedNCT00577421
What this trial is testing

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Who this might be right for
Postmenopausal Osteoporosis
Warner Chilcott 32
Not applicableStudy completedNCT06646549
What this trial is testing

Insomnia in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Beylikduzu State Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00079521
What this trial is testing

Therapeutic Touch for Wrist Fractures in Postmenopausal Women

Who this might be right for
OsteoporosisFractures
National Center for Complementary and Integrative Health (NCCIH) 125
Not applicableStudy completedNCT04748029
What this trial is testing

Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, PostmenopausalOsteoporotic Fractures
Ufuk University 139
Post-approval studies (Phase 4)Study completedNCT05884372
What this trial is testing

Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)

Who this might be right for
Osteoporosis in Postmenopausal Women
Xi'an Honghui Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT00529373
What this trial is testing

MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)

Who this might be right for
Postmenopausal Osteoporosis
Merck Sharp & Dohme LLC 16,071
Post-approval studies (Phase 4)Not Yet RecruitingNCT07772609
What this trial is testing

Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

Who this might be right for
Osteoporosis in Post-menopausal Women
Sahlgrenska University Hospital 216
Large-scale testing (Phase 3)UnknownNCT06154187
What this trial is testing

Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Pharmbio Korea Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00532207
What this trial is testing

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT00191867
What this trial is testing

Clinical Trial of Teriparatide in Japan

Who this might be right for
Osteoporosis
Eli Lilly and Company 160
Not applicableEnded earlyNCT04271605
What this trial is testing

Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD)

Who this might be right for
Osteoporosis, Postmenopausal
National Taiwan University Hospital 5
Large-scale testing (Phase 3)Study completedNCT00670319
What this trial is testing

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 7,705
Post-approval studies (Phase 4)Study completedNCT00271713
What this trial is testing

Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)

Who this might be right for
Osteoporosis, Postmenopausal
Charite University, Berlin, Germany 70
Not applicableStudy completedNCT04942691
What this trial is testing

Prevention of Osteoporosis: Effects of Mini-trampoline Training on the Bone Remodeling

Who this might be right for
Perimenopausal Bone LossPostmenopausal Osteopenia
University of Palermo 40
Testing effectiveness (Phase 2)Ended earlyNCT03165747
What this trial is testing

Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women

Who this might be right for
Menopausal Osteoporosis
Emory University 35
Large-scale testing (Phase 3)Looking for participantsNCT07062978
What this trial is testing

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Who this might be right for
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd. 278
Not applicableStudy completedNCT00443716
What this trial is testing

Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

Who this might be right for
OsteoporosisPostmenopausal
Mayo Clinic 60
Testing effectiveness (Phase 2)Ended earlyNCT00078026
What this trial is testing

An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass

Who this might be right for
Osteoporosis
Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT00767299
What this trial is testing

Arzoxifene to Treat Korean Women With Osteoporosis

Who this might be right for
Osteoporosis
Eli Lilly and Company 91
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation